Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The Brazilian database on pregnancy in multiple sclerosis.

Finkelsztejn A, Fragoso YD, Ferreira ML, Lana-Peixoto MA, Alves-Leon SV, Gomes S, Damasceno BP, Mendes MF, Salgado PR, Correa EC, Comini-Frota ER, Diniz DS, Gama PD, Kaimen-Maciel DR, Morales RR, Arruda WO, Grzesiuk AK, Khouri JM, Lopes JS, Rocha CF, Domingues R, Gonçalves MV, Lorenti MA, Parolin MK, Siquineli F, Tosta ED, Brooks JB, Gallina AS, Melges LD, Ruocco HH.

Clin Neurol Neurosurg. 2011 May;113(4):277-80. doi: 10.1016/j.clineuro.2010.11.016. Epub 2010 Dec 15.

PMID:
21159421
2.

Pregnancy and multiple sclerosis: the initial results from a Brazilian database.

Fragoso YD, Finkelsztejn A, Comini-Frota ER, da Gama PD, Grzesiuk AK, Khouri JM, Alves-Leon SV, Morales Rde R, Lana-Peixoto MA, Rocha CF.

Arq Neuropsiquiatr. 2009 Sep;67(3A):657-60.

3.

Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).

Fernández Liguori N, Klajn D, Acion L, Cáceres F, Calle A, Carrá A, Cristiano E, Deri N, Garcea O, Jaureguiberry A, Onaha P, Patrucco L, Riccio P, Rotta Escalante R, Saladino Ml, Sinay V, Tarulla A, Villa A.

Mult Scler. 2009 May;15(5):555-62. doi: 10.1177/1352458509102366. Epub 2009 Mar 19.

PMID:
19299437
4.

Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.

Wiendl H, Hohlfeld R.

Neurology. 2009 Mar 17;72(11):1008-15. doi: 10.1212/01.wnl.0000344417.42972.54. Review.

PMID:
19289741
5.

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.

Veugelers PJ, Fisk JD, Brown MG, Stadnyk K, Sketris IS, Murray TJ, Bhan V.

Mult Scler. 2009 Nov;15(11):1286-94. doi: 10.1177/1352458509350307. Epub 2009 Oct 30.

PMID:
19965558
6.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Weber-Schoendorfer C, Schaefer C.

Mult Scler. 2009 Sep;15(9):1037-42. doi: 10.1177/1352458509106543.

PMID:
19692433
7.

Pregnancy, delivery, and birth outcome in women with multiple sclerosis.

Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE.

Neurology. 2005 Dec 27;65(12):1961-3.

PMID:
16380620
8.

Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis.

Fragoso YD, Frota ER, Lopes JS, Noal JS, Giacomo MC, Gomes S, Gonçalves MV, da Gama PD, Finkelsztejn A.

Clin Neuropharmacol. 2010 Nov-Dec;33(6):312-6. doi: 10.1097/WNF.0b013e3181f8d513. Review.

PMID:
21079457
9.

The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.

Fragoso YD, Boggild M, Macias-Islas MA, Carra A, Schaerer KD, Aguayo A, de Almeida SM, Alvarenga MP, Alvarenga RM, Alves-Leon SV, Arruda WO, Brooks JB, Comini-Frota ER, Ferreira ML, Finkelsztejn A, Finkelsztejn JM, de Freitas LD, Gallina AS, da Gama PD, Georgetto S, Giacomo MC, Gomes S, Gonçalves MV, Grzesiuk AK, Kaimen-Maciel DR, Lopes J, Lourenco GA, Malfetano FR, Morales NM, Morales Rde R, Oliveira CL, Onaha P, Patroclo C, Ribeiro SB, Ribeiro TA, Salminen HJ, Santoro P, Seefeld M, Soares PV, Tarulla A, Vasconcelos CC.

Clin Neurol Neurosurg. 2013 Feb;115(2):154-9. doi: 10.1016/j.clineuro.2012.04.024. Epub 2012 May 26.

PMID:
22633835
10.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
11.

Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.

Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T.

J Neurol Sci. 2011 Apr 15;303(1-2):109-13. doi: 10.1016/j.jns.2010.12.024. Epub 2011 Jan 19.

PMID:
21251671
12.

Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.

Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand S, Nessler S, Rothhammer V, Lang M, Hartung HP, Hemmer B.

Arch Neurol. 2009 Oct;66(10):1216-23. doi: 10.1001/archneurol.2009.138. Epub 2009 Aug 10.

PMID:
19667211
13.

Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.

Airas L, Jalkanen A, Alanen A, Pirttilä T, Marttila RJ.

Neurology. 2010 Aug 3;75(5):474-6. doi: 10.1212/WNL.0b013e3181eb5860. No abstract available.

PMID:
20679640
14.

Extended use of glatiramer acetate (Copaxone) for MS.

Greenstein JI.

Neurology. 1999 Mar 10;52(4):897-8. No abstract available.

PMID:
10078765
15.

Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies.

Antel JP, Miron VE.

Clin Neurol Neurosurg. 2008 Nov;110(9):951-7. doi: 10.1016/j.clineuro.2008.03.021. Epub 2008 May 27. Review.

PMID:
18502570
16.

Pregnancy in renal transplant patients.

Moon JI, Park SG, Cheon KO, Kim SI, Kim YS, Park YW, Park K.

Transplant Proc. 2000 Nov;32(7):1869-70. No abstract available.

PMID:
11119976
17.

Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study.

Chen YH, Lin HL, Lin HC.

Mult Scler. 2009 May;15(5):606-12. doi: 10.1177/1352458508101937. Epub 2009 Mar 24.

PMID:
19318510
18.

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

Charles JA, Tremlett H, Lu E, Guimond C, Sadovnick AD.

Neurology. 2013 Mar 12;80(11):1068-9. doi: 10.1212/01.wnl.0000428359.07207.f6. Review.

PMID:
23479468
19.

Pregnancy and multiple sclerosis.

Abramsky O.

Ann Neurol. 1994;36 Suppl:S38-41. Review. No abstract available.

PMID:
7517125
20.

Childbirth after renal transplantation.

Pahl MV, Vaziri ND, Kaufman DJ, Martin DC.

Transplant Proc. 1993 Aug;25(4):2727-31. No abstract available.

PMID:
8356728

Supplemental Content

Support Center